Johan Kolmert is assistant professor in the Unit for Integrative Metabolomics (Craig Wheelock’s lab), the Institute of Environmental Medicine, at the Karolinska Institute. Johan’s research has focused on demonstrating the utility of a bioanalytical workflow for eicosanoid-lipidomics in urine that can identify molecular subgroups of asthmatics beyond the standard clinical diagnosis definition. Johan is a trained analytical chemist from AstraZeneca R&D and is currently working with several larger European- and Swedish-funded studies on severe asthma. His research in molecular phenotyping also aims to support new ways of identifying patient responders/non-responders to current standard asthma treatment, including the new antibody-based therapies for “type 2 biomarker high”-patients.
Johan is frequently presenting his research at the leading international conferences in respiratory medicine, European Respiratory Society (ERS) and American Thoracic Society (ATS).
With 20 years of experience in bioanalytical applications Johan is also acting as bioanalytical consultant supporting small Swedish pharmaceutical companies in pharmacokinetics/pharmacodynamics strategies during their pre-clinical and clinical drug development programs to treat inflammatory diseases. “